Start with the exact product and the concern to assess
DI’s published schedule lists standard dermal filler at KRW 120,000 per 1 cc. All listed prices exclude VAT. The schedule preserves 11 September 2026 amounts; confirm a current written quote. The word standard does not identify a brand, material or licensed indication.
Explain the change you want to discuss, then ask the clinician to name the proposed material and product and why it fits the assessed concern. Do not select an amount from a photograph or assume that the cheapest per-cc price provides an equivalent plan. An assessment may suggest a different approach or no treatment.
A filler name does not tell you everything
Dermal fillers are used to add volume or soften particular contours, but the material and intended area matter. Products can differ in their persistence and how a complication or removal would be managed. Do not assume every filler is hyaluronic acid, temporary, or readily reversible.
The FDA’s patient information is a useful source for general risk questions, but its approvals refer to specific United States uses. They do not establish Korean authorization of a product or prove what DI uses. Ask for the product’s identity and the local regulatory and indication information relevant to your proposed treatment.
Compare volume and the complete scope, not a single number
A per-cc entry is a unit price, not an automatic one-syringe treatment plan or a promise of how much you need. Ask the clinician to explain the assessed amount, whether the quotation covers more than one area, and what will be recorded about the product used.
Use a written comparison to separate the quoted procedure from consultation, VAT, anesthesia if applicable, medicines, other procedures, reviews and any future treatment. Ask how unused material and any later adjustment are handled. These are points to clarify, not assumed DI policies.
| Confirm this | Write down the answer |
|---|---|
| Product and material | Exact name, relevant indication and proposed area |
| Amount and scope | Assessed volume and the areas included |
| Total charges | Current procedure price, VAT and separate fees |
| Aftercare | Review access and who evaluates an unexpected problem |
Prepare the history that changes the discussion
Tell the clinician about previous fillers, implants and other treatments, including the location, approximate date and known product. Bring records if available; an old injection can be relevant even when its visible effect has changed. Do not guess an unknown brand to complete a form.
The AAD recommends discussing medical conditions, allergies, bleeding problems, cold sores, skin irritation and all medicines or supplements. Describe prior reactions and active skin concerns. Do not stop prescribed medication on your own; the appropriate clinicians should advise about any change.
Understand common reactions and serious complications
Redness, swelling, tenderness and bruising can occur after filler. Their presence does not establish a personal diagnosis or a safe waiting period. Ask what is expected for your assessed area, how to contact the clinic and when a review is needed.
Unintentional injection into a blood vessel is a serious risk. The FDA describes possible tissue damage, vision loss and stroke, and notes that some complications can be permanent. Removal or reduction can also require treatment and may be difficult. Discuss the treating clinician’s response arrangements before deciding; do not treat a product label or an AI illustration as a safety guarantee.
Concerning symptoms need prompt medical assessment
Seek immediate medical attention for unusual pain, vision changes, white, gray or blue skin near the injection area, or signs of stroke after filler. Do not wait for a social-media reply or for your return flight. Severe allergic symptoms also require emergency care. The source for these warning signs is the FDA’s patient advice.
Before leaving, obtain a written contact and escalation plan that explains routine questions and emergencies. For an international visit, clarify which service can examine you outside clinic hours and after you return home. This article does not diagnose a complication or provide a self-treatment protocol.
Plan review time and keep the decision individual
Ask how the proposed product and area affect expected persistence, possible changes over time and review timing. Do not transfer a general duration range from a different filler or area to your own plan. Booking repeat treatment automatically is different from reassessing whether it is appropriate.
Confirm language arrangements and fees before travelling to DI at 12F, Seosan Building, 441 Gangnam-daero, Seocho-gu, Seoul. Share possible dates through the official consultation page, leaving room for assessment and follow-up. There is no universal injection-to-flight interval here, and submitting an inquiry does not confirm an appointment.
Read this guide and its illustrations in context
The three diagrams explain product questions, warning signs and an itemized quote. They are AI-generated educational images, not patient photographs, treatment results, actual product packaging or an injection map. The sources below are general patient information and do not endorse DI or verify its treatment outcomes.
Editorial information updated 6 November 2026; no new medical-review certification is claimed. A clinical consultation should address realistic limits, alternatives and the option not to proceed. Individual results vary. #DIPlasticSurgery #DermalFiller #Seoul
Information that helps us prepare a useful reply
When contacting the clinic, tell us the procedure or concern you would like to discuss, your preferred language, whether you have had related treatment before and the dates you could visit Seoul. International patients may also wish to include their arrival and departure dates so the team can explain when an in-person consultation and follow-up may fit into the trip.
Please do not send passport numbers, payment information or complete medical records through an initial website inquiry. A coordinator can explain which health information or photographs are relevant and how they should be shared. Online guidance is preliminary; suitability, technique and the final treatment plan are determined only after an appropriate medical assessment.